An early-phase development activity involving the investigation of multiple synthetic pathways to identify the most efficient, scalable, and economically viable route for manufacturing a new Active Pharmaceutical Ingredient.
Meet us at Tides Europe 2026, Stand No. 805, Nov 3-5, RAI Amsterdam, Netherlands Schedule a Meeting
Explore how Neuland supports API programs from pre-IND through commercial manufacturing.